Our head of Business Development & Outsourcing, Samuel Mercer will be at  #BIOEurope in Copenhagen Nov. 4-8. We will be exploring partnering opportunities for embodiments of our platform-based technology: lead product candidate, EP-104, a novel long-term-release pain and inflammation treatment for knee #osteoarthritis, and pipeline assets in post-operative pain and infection.